The Instagram stars of therapeutic areas and disease management, Digital Opinion Influencers (DOIs) are a growing online presence that often can as effectively communicate and advocate for pharmaceutical solutions and products as Key Opinion Leaders (KOLs) do in more traditional channels (publications, conference presentations, perhaps even treating patients). The possibility of that very comparison makes [...]
Let's talk real world science! Leveraging real-world data and scientific evidence when making strategic decisions has never been more important—in the pharmaceutical world, at least. Though done here most convincingly, Arx Research isn’t the only research firm to notice and empirically confirm that physicians and thought leaders by and large want their discussions with pharma [...]
Intending to engage thought leaders is one thing, succeeding is another. The difficulty to access KOLs is based on a number of factors. First, there is the level of influence a KOL may have. Internationally recognized thought leaders are always more difficult to engage with than local influencers. KOL access will also vary based on the type of KOL [...]
What KOLs think of MSLs? The good news is that everyone is doing a fairly good job! The bad news is…well there isn’t much bad news here. It seems KOLs really appreciate MSLs, maybe with just a few that don’t excel but no real bad apples! Overall ranking assessment of the quality of the relationships [...]
Arx analysts completed a study on strategies used by pharmaceutical organizations when engaging thought leaders during each phase of a product’s lifecycle; The white paper "Developing Lifecycle-based KOL Engagement Strategies" presents key study findings. 70% of surveyed companies employ lifecycle phase approaches to engage with thought leaders 24% of surveyed respondents reported their company begins developing relationships [...]
This Fact Sheet presents best practices for European KOL Interactions, revealing the difference between the current frequency of interactions, as experienced by more than 130 surveyed thought leaders and what they think would be the best pace for the industry to adopt. Thought leaders are an important component of the life science ecosystem and their [...]
